Spotlight
FDA Grants Premarket Clearance of Asuragen’s AmplideX® Fragile X Dx and Carrier Screen Kit
Our AmplideX® Fragile X Dx and Carrier Screen Kit has been cleared by the United States Food and Drug Administration (FDA), making it the first and only test for the detection and quantification of expanded pathogenic repeat sequences to be cleared by the FDA.
Learn More